Shandong Pharmaceutical Group disclosed its semi-annual report on August 24. The company achieved operating income of 2.28 billion yuan in the first half of the year, up 1.34% year on year; net profit attributable to shareholders of listed companies was 371 million yuan, down 0.07% year on year; and basic earnings per share were 0.5589 yuan/share. The company plans to distribute a cash dividend of 3 yuan for every 10 shares to all shareholders.

Shandong Pharmaceutical Group disclosed its semi-annual report on August 24. The company achieved operating income of 2.28 billion yuan in the first half of the year, up 1.34% year on year; net profit attributable to shareholders of listed companies was 371 million yuan, down 0.07% year on year; and basic earnings per share were 0.5589 yuan/share. The company plans to distribute a cash dividend of 3 yuan for every 10 shares to all shareholders.